This study showed that NIHSS score, cerebral infarct volume, NSE, and S100β were all lower in both groups after treatment compared to before treatment in this group, and the difference was statistically significant when the observation group was lower than the comparison group after treatment. This evidence concerns the gene S100B and brain infarction.